Impact of Pretreatment Anemia on Upfront Abiraterone Acetate Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter Retrospective Study
Teppei Okamoto(Hirosaki University), Chikara Οhyama(Hirosaki University), Tomonori Habuchi(Akita University), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization), Norihiko Tsuchiya(Yamagata University), Daisuke Noro(Hirosaki University), Jiro Shimoda(Iwate Prefectural Central Hospital), Shigeto Ishidoya(Sendai City Hospital), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Senji Hoshi, Toshikazu Tanaka, Shintaro Narita(Akita University), Toshihiko Sakurai(Sojo University), Toshiaki Kawaguchi(Aomori Prefectural Central Hospital), Akihiko Ito(The University of Tokyo), Shingo Hatakeyama(Hirosaki University)
Cited by 0
Related Papers
The Global Methane Budget 2000-2017
|NOAA Institutional Repository|2019|2.7k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
|New England Journal of Medicine|2020|1.5k
The global methane budget 2000–2012
|Earth system science data|2016|1.1k